Pfizer and Myovant’s endometriosis pain drug Myfembree gets another FDA nod

After months of delay in its decision, the FDA has given a green light to Pfizer and Myovant’s drug Myfembree for pain related endometriosis, a gynecological condition associated with moderate to severe pain, making it the drug’s second indication approval.